Cargando…

Biological artificial valve dysfunction – single-centre, observational echocardiographic study in patients operated on before age 65 years

INTRODUCTION: Patients with implanted bioprostheses are at risk of structural dysfunction which results from the limited durability of biological valves. The aim of this study was to analyse the mechanism of bioprosthesis degeneration and to evaluate the usability of transthoracic and transoesophage...

Descripción completa

Detalles Bibliográficos
Autores principales: Maciejewski, Marek, Piestrzeniewicz, Katarzyna, Bielecka-Dabrowa, Agata, Walczak, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264991/
https://www.ncbi.nlm.nih.gov/pubmed/22328882
http://dx.doi.org/10.5114/aoms.2011.26611
_version_ 1782222027057266688
author Maciejewski, Marek
Piestrzeniewicz, Katarzyna
Bielecka-Dabrowa, Agata
Walczak, Andrzej
author_facet Maciejewski, Marek
Piestrzeniewicz, Katarzyna
Bielecka-Dabrowa, Agata
Walczak, Andrzej
author_sort Maciejewski, Marek
collection PubMed
description INTRODUCTION: Patients with implanted bioprostheses are at risk of structural dysfunction which results from the limited durability of biological valves. The aim of this study was to analyse the mechanism of bioprosthesis degeneration and to evaluate the usability of transthoracic and transoesophageal echocardiography in determining the indications for reoperation in 117 patients with a bioprosthesis implanted before 65 years old. MATERIAL AND METHODS: The study comprised 117 consecutive patients (M – 27, F – 90, age 48-74 years, 57.5 ±9.5 years) with a bioprosthesis implanted under the age of 65, who were examined in accordance with the accepted protocol and whose complete clinical and echocardiographic documentation was collected. The scheduled echocardiographic examination was performed annually from the 5 year after implantation of the bioprosthesis in patients with a valve implanted over the age of 35 years and from the 1 year after bioprosthesis implantation in patients with a prosthesis implanted at a younger age. Unscheduled echocardiographic examinations were performed only on clinical indications. RESULTS: During the period under observation, due to degeneration of the bioprosthesis 76 patients were reoperated, including 62 patients with mitral bioprostheses. In 88.7% of patients with degeneration of mitral valve bioprostheses, regurgitation was observed. In 69% of patients with aortic bioprostheses, valve dysfunction was the dominant mechanism of stenosis. CONCLUSIONS: The most common mechanism of structural dysfunction of a mitral bioprosthesis is regurgitation caused by prolapse or perforation of one of the leaflets. Degeneration of an aortic bioprosthesis usually results in aortic stenosis. In cases of bioprosthesis degeneration connected with stenosis, transthoracic echocardiography was sufficient for the evaluation of valve dysfunction. In the case of bioprosthesis dysfunction accompanied by regurgitation, transoesophageal echocardiography was more informative to decide when the operation should be performed.
format Online
Article
Text
id pubmed-3264991
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-32649912012-02-10 Biological artificial valve dysfunction – single-centre, observational echocardiographic study in patients operated on before age 65 years Maciejewski, Marek Piestrzeniewicz, Katarzyna Bielecka-Dabrowa, Agata Walczak, Andrzej Arch Med Sci Clinical Research INTRODUCTION: Patients with implanted bioprostheses are at risk of structural dysfunction which results from the limited durability of biological valves. The aim of this study was to analyse the mechanism of bioprosthesis degeneration and to evaluate the usability of transthoracic and transoesophageal echocardiography in determining the indications for reoperation in 117 patients with a bioprosthesis implanted before 65 years old. MATERIAL AND METHODS: The study comprised 117 consecutive patients (M – 27, F – 90, age 48-74 years, 57.5 ±9.5 years) with a bioprosthesis implanted under the age of 65, who were examined in accordance with the accepted protocol and whose complete clinical and echocardiographic documentation was collected. The scheduled echocardiographic examination was performed annually from the 5 year after implantation of the bioprosthesis in patients with a valve implanted over the age of 35 years and from the 1 year after bioprosthesis implantation in patients with a prosthesis implanted at a younger age. Unscheduled echocardiographic examinations were performed only on clinical indications. RESULTS: During the period under observation, due to degeneration of the bioprosthesis 76 patients were reoperated, including 62 patients with mitral bioprostheses. In 88.7% of patients with degeneration of mitral valve bioprostheses, regurgitation was observed. In 69% of patients with aortic bioprostheses, valve dysfunction was the dominant mechanism of stenosis. CONCLUSIONS: The most common mechanism of structural dysfunction of a mitral bioprosthesis is regurgitation caused by prolapse or perforation of one of the leaflets. Degeneration of an aortic bioprosthesis usually results in aortic stenosis. In cases of bioprosthesis degeneration connected with stenosis, transthoracic echocardiography was sufficient for the evaluation of valve dysfunction. In the case of bioprosthesis dysfunction accompanied by regurgitation, transoesophageal echocardiography was more informative to decide when the operation should be performed. Termedia Publishing House 2011-12-30 2011-12-31 /pmc/articles/PMC3264991/ /pubmed/22328882 http://dx.doi.org/10.5114/aoms.2011.26611 Text en Copyright © 2011 Termedia & Banach http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Research
Maciejewski, Marek
Piestrzeniewicz, Katarzyna
Bielecka-Dabrowa, Agata
Walczak, Andrzej
Biological artificial valve dysfunction – single-centre, observational echocardiographic study in patients operated on before age 65 years
title Biological artificial valve dysfunction – single-centre, observational echocardiographic study in patients operated on before age 65 years
title_full Biological artificial valve dysfunction – single-centre, observational echocardiographic study in patients operated on before age 65 years
title_fullStr Biological artificial valve dysfunction – single-centre, observational echocardiographic study in patients operated on before age 65 years
title_full_unstemmed Biological artificial valve dysfunction – single-centre, observational echocardiographic study in patients operated on before age 65 years
title_short Biological artificial valve dysfunction – single-centre, observational echocardiographic study in patients operated on before age 65 years
title_sort biological artificial valve dysfunction – single-centre, observational echocardiographic study in patients operated on before age 65 years
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264991/
https://www.ncbi.nlm.nih.gov/pubmed/22328882
http://dx.doi.org/10.5114/aoms.2011.26611
work_keys_str_mv AT maciejewskimarek biologicalartificialvalvedysfunctionsinglecentreobservationalechocardiographicstudyinpatientsoperatedonbeforeage65years
AT piestrzeniewiczkatarzyna biologicalartificialvalvedysfunctionsinglecentreobservationalechocardiographicstudyinpatientsoperatedonbeforeage65years
AT bieleckadabrowaagata biologicalartificialvalvedysfunctionsinglecentreobservationalechocardiographicstudyinpatientsoperatedonbeforeage65years
AT walczakandrzej biologicalartificialvalvedysfunctionsinglecentreobservationalechocardiographicstudyinpatientsoperatedonbeforeage65years